AI-generated summary
The authors reviewed eight randomized controlled trials of intravascular laser irradiation of blood (ILIB), which included 340 participants across several conditions. They report reductions in pain, inflammatory markers and oxidative stress, along with improved quality-of-life scores, and no serious adverse events. The authors note that four of the eight studies were judged at some concern for risk of bias and call for standardized dosimetry and longer-term outcomes.
- Participants
- 340
- Studies included
- 8
- Who or what was studied
- Adults and children with conditions including cardiovascular disease, diabetic neuropathy, osteoarthritis, spinal cord injury, chronic endometritis, cellulite, and pediatric dental anxiety
- Limits stated in the abstract
- The authors state that four of the eight included trials had some concerns about risk of bias and that standardized dosimetry and long-term outcomes remain needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial, Oxidative stress, Photobiomodulation therapy, Inflammation, Photobiomodulation, Osteoarthritis, Neuropathy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.